Prognostic value of circumferential resection margin in T3N0M0 esophageal squamous cell carcinoma

被引:5
|
作者
Yang, Yu-Shang [1 ]
Wang, Yun-Cang [2 ]
Deng, Han-Yu [1 ]
Yuan, Yong [1 ]
Wang, Zhi-Qiang [3 ]
He, Du [4 ]
Chen, Long-Qi [1 ]
机构
[1] Sichuan Univ, Dept Thorac Surg, West China Hosp, 37 Guoxue Alley, Chengdu 610041, Peoples R China
[2] Hosp Chengdu Off Peoples Govt Tibetan Autonomous, Dept Thorac Surg, Chengdu 610041, Peoples R China
[3] Chongqing Canc Inst & Hosp & Canc Ctr, Dept Thorac Surg, Chongqing 404100, Peoples R China
[4] Sichuan Univ, Dept Pathol, West China Hosp, Chengdu 610041, Peoples R China
关键词
Esophageal squamous cell carcinoma (ESCC); Royal College of Pathologists Criteria; College of American Pathologists Criteria; circumferential resection margin (CRM); RECTAL-CANCER; LYMPH-NODES; NEOADJUVANT; SURVIVAL; NUMBER; EXTENT;
D O I
10.21037/atm.2018.06.49
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The prognostic value of positive circumferential resection margins (CRM) in resected esophageal squamous cell carcinoma (ESCC) is unclear. The Royal College of Pathologists criteria and the College of American Pathologists criteria are the two commonly used definitions of CRM involvement. The aim of this report was to compare the prognostic performance of the two criteria and to propose a modified stratification in patients who underwent radical esophagectomy for ESCC. Methods: We retrospectively reviewed 112 patients with pathologically confirmed T3NOMO ESCC and without neoadjuvant therapy from June 2009 and July 2011. The optimal cutoff point was obtained by the X-tile. The prognostic performance of different classifications of CRM was assessed in terms of homogeneity, discriminatory ability, and monotonicity. Results: According to the Royal College of Pathologists criteria, a positive CRM was detected in 87 patients (77.7%); and 24 patients (21.4%) were found with positive CRM according to the College of American Pathologists criteria. Non-significant associations between overall survival and CRM were observed according to either of the two criteria. The analysis of reclassifying the CRM criteria demonstrated that the optimal cutoff CRM value for best prognostic power was 600 pm. Patients with CRM more than 600 pm showed better overall survival (P<0.05) than the cases with CRM less than 600 pm. Furthermore, the improved homogeneity, discriminatory ability, and monotonicity gradients were also found in this modified criteria, as compared with the two existing criteria. Conclusions: Our study highlighted that CRM was an independent prognostic factor for survival in esophageal cancer patients, and the modified CRM criteria had better prognostic power than the traditional criteria in patients with ESCC.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Adjuvant therapy for pathological T3N0M0 esophageal squamous cell carcinoma
    Zhang, Xiaobin
    Yang, Yu
    Sun, Yifeng
    Ye, Bo
    Guo, Xufeng
    Mao, Teng
    Hua, Rong
    Li, Bin
    Gu, Haiyong
    Liu, Jun
    Li, Zhigang
    JOURNAL OF THORACIC DISEASE, 2019, 11 (06) : 2512 - 2522
  • [2] Postoperative Chemotherapy for Thoracic Pathological T3N0M0 Esophageal Squamous Cell Carcinoma
    Audrey E. Kam
    Sam G. Pappas
    Ashiq Masood
    Annals of Surgical Oncology, 2020, 27 : 1314 - 1315
  • [3] Postoperative Chemotherapy for Thoracic Pathological T3N0M0 Esophageal Squamous Cell Carcinoma
    Wang, Qifeng
    Peng, Lin
    Li, Tao
    Dai, Wei
    Jiang, Yinchun
    Xie, Tianpeng
    Fang, Qiang
    Wang, Yi
    Wu, Lei
    Cao, Bangrong
    Han, Yongtao
    Lang, Jinyi
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (05) : 1488 - 1495
  • [4] Survival Outcomes for Patients With T3N0M0 Squamous Cell Carcinoma of the Glottic Larynx
    Ko, Huaising C.
    Harari, Paul M.
    Chen, Shuai
    Wieland, Aaron M.
    Yu, Menggang
    Baschnagel, Andrew M.
    Kimple, Randall J.
    Witek, Matthew E.
    JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2017, 143 (11) : 1126 - 1133
  • [5] Survival Outcomes for Patients With T3N0M0 Squamous Cell Carcinoma of the Glottic Larynx
    D'Ascanio, Luca
    Piazza, Fabio
    JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2018, 144 (06) : 542 - 543
  • [6] Survival Outcomes for Patients With T3N0M0 Squamous Cell Carcinoma of the Glottic Larynx Reply
    Witek, Matthew E.
    Hartig, Gregory K.
    Harari, Paul M.
    JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2018, 144 (06) : 543 - 543
  • [7] Prognostic relevance of β-catenin expression in T2-3N0M0 esophageal squamous cell carcinoma
    Situ, Dong-Rong
    Hu, Yi
    Zhu, Zhi-Hua
    Wang, Jian
    Long, Hao
    Rong, Tie-Hua
    WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (41) : 5195 - 5202
  • [8] Prognostic relevance of β-catenin expression in T2-3N0M0 esophageal squamous cell carcinoma
    Dong-Rong Situ
    Tie-Hua Rong
    World Journal of Gastroenterology, 2010, 16 (41) : 5195 - 5202
  • [9] T3N0M0 GLOTTIC CARCINOMA - A FAILURE ANALYSIS
    LUNDGREN, JAV
    GILBERT, RW
    VANNOSTRAND, AWP
    HARWOOD, AR
    KEANE, TJ
    BRIANT, TDR
    CLINICAL OTOLARYNGOLOGY, 1988, 13 (06) : 455 - 465
  • [10] TREATMENT DECISIONS IN T3N0M0 GLOTTIC CARCINOMA
    BRYANT, GP
    POULSEN, MG
    TRIPCONY, L
    DICKIE, GJ
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 31 (02): : 285 - 293